Hypermethylation of miR-107, miR-130b, miR-203a, miR-1258 Genes Associated with Ovarian Cancer Development and Metastasis
- Авторлар: Loginov V.I.1,2, Burdennyy A.M.1, Filippova E.A.1, Pronina I.V.1, Kazubskaya T.P.3, Kushlinsky D.N.3, Ermilova V.D.3, Rykov S.V.4, Khodyrev D.S.4,5, Braga E.A.1,2
-
Мекемелер:
- Institute of General Pathology and Pathophysiology
- Research Center of Medical Genetics
- Blokhin Russian Cancer Research Center
- State Research Institute for Genetics and Selection of Industrial Microorganisms, Kurchatov Institute National Research Center
- Federal Research Clinical Center of Specialized Types of Medical Care and Medical Technologies, Federal Biomedical Agency of Russia
- Шығарылым: Том 52, № 5 (2018)
- Беттер: 693-700
- Бөлім: Molecular Cell Biology
- URL: https://journal-vniispk.ru/0026-8933/article/view/163676
- DOI: https://doi.org/10.1134/S0026893318050102
- ID: 163676
Дәйексөз келтіру
Аннотация
It is known that microRNAs (miRNAs) are able to dynamically regulate gene expression. At the same time, methylation can reduce expression of miRNA encoding genes and, therefore, reduce their inhibitory effects on mRNAs of target genes, including those of oncogenes, that promoting the development of tumors of different localization. The role of miRNA hypermethylation in the pathogenesis of ovarian cancer is not completely understood; so we conducted a search for new hypermethylated and potentially suppressor miRNA genes in ovarian tumors. Four new miRNA genes (MIR-107, MIR-130b, MIR-203a, MIR-1258) commonly hypermethylated (28‒52% ) in tumor tissues vs 4‒7% in paired histologically normal tissues, p < 0.01, were identified in a representative set of 54 ovarian cancer samples using methylation-specific PCR. It was shown that hypermethylation of MIR-130b, MIR-203a, and MIR-1258 genes is significantly (p ≤ 0.05) associated with metastasis of ovarian cancer. These results suggest the involvement of four miRNAs (miR-107, miR-130b, miR-203a, and miR-1258) and hypermethylation of their encoding genes in the pathogenesis of ovarian cancer.
Негізгі сөздер
Авторлар туралы
V. Loginov
Institute of General Pathology and Pathophysiology; Research Center of Medical Genetics
Хат алмасуға жауапты Автор.
Email: loginov7w@gmail.com
Ресей, Moscowa, 125315; Moscow, 115478
A. Burdennyy
Institute of General Pathology and Pathophysiology
Email: eleonora10_45@mail.ru
Ресей, Moscowa, 125315
E. Filippova
Institute of General Pathology and Pathophysiology
Email: eleonora10_45@mail.ru
Ресей, Moscowa, 125315
I. Pronina
Institute of General Pathology and Pathophysiology
Email: eleonora10_45@mail.ru
Ресей, Moscowa, 125315
T. Kazubskaya
Blokhin Russian Cancer Research Center
Email: eleonora10_45@mail.ru
Ресей, Moscow, 115478
D. Kushlinsky
Blokhin Russian Cancer Research Center
Email: eleonora10_45@mail.ru
Ресей, Moscow, 115478
V. Ermilova
Blokhin Russian Cancer Research Center
Email: eleonora10_45@mail.ru
Ресей, Moscow, 115478
S. Rykov
State Research Institute for Genetics and Selection of Industrial Microorganisms,Kurchatov Institute National Research Center
Email: eleonora10_45@mail.ru
Ресей, Moscow, 117545
D. Khodyrev
State Research Institute for Genetics and Selection of Industrial Microorganisms,Kurchatov Institute National Research Center; Federal Research Clinical Center of Specialized Types of Medical Care and Medical Technologies,
Federal Biomedical Agency of Russia
Email: eleonora10_45@mail.ru
Ресей, Moscow, 117545; Moscow, 115682
E. Braga
Institute of General Pathology and Pathophysiology; Research Center of Medical Genetics
Хат алмасуға жауапты Автор.
Email: eleonora10_45@mail.ru
Ресей, Moscowa, 125315; Moscow, 115478
Қосымша файлдар
